Optimizing Atrial Fibrillation Management

Slides:

Advertisements

Similar presentations

CHADS 2 -> CHA 2 DS 2 VASc. CHA2DS2-VASc Risk Score CHF or LVEF < 40% 1 Hypertension1 Age > 752 Diabetes1 Stroke/TIA/ Thromboembolism 2 Vascular Disease.

Advertisements

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. Benefit of Anticoagulation Unlikely in Patients With Atrial.

Volume 32, Issue 1, Pages (July 1957)

Volume 32, Issue 1, Pages (July 1957)

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Tell-tale Telangiectasias

Colloquium on Therapy of Right Heart Failure

Volume 146, Issue 5, Pages (November 2014)

When to Be Rash About a Fever and Headache

Volume 56, Issue 1, Pages (July 1969)

Volume 100, Issue 6, Pages (December 1991)

Epidemiology and Treatment of Lung Cancer in Seattle

Bovine Tuberculosis Eradication

Improved Ventilatory Response to Exercise after Cardioversion of Chronic Atrial Fibrillation to Sinus Rhythm Torbjörn Lundström, M.D., Östen Karlsson,

Making Decisions About Antithrombotic Therapy in Heart Disease

Hyperbaric Oxygenation in Cardiac and Pulmonary Disease

Air Pollution and Chest Disease

Rheumatic Heart Disease in East Pakistan

Navin K. Jain, MD, Thiam H. Lie, MD, FCCP CHEST

Fever, Skin Eruption, Low Serum Gammaglobulin in a Child with Leukemia

Cardiac Arrhythmias in Acute Myocardial Infarction II

Frank W. Ewald, MD, FCCP, Albert H. Scherff, MD CHEST

Volume 13, Issue 6, Pages (June 2016)

Circ Cardiovasc Qual Outcomes

Role of the CHADS2 Score in Acute Coronary Syndromes

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

CHADS2 Score Predicts Postoperative Atrial Fibrillation in Patients Undergoing Elective Pulmonary Lobectomy Svetlana Kotova, MD, Mansen Wang, PhD, Katie.

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Laurent Macle, MD, John Cairns, MD, Kori.

Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control

Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation Lena Rivard, MD, MSc, Paul Khairy, MD,

Volume 137, Issue 2, Pages (February 2010)

Acute Pulmonary Exacerbations of Sarcoidosis

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Long-Term Risk of Ischemic Stroke After the Cox-Maze III Procedure for Atrial Fibrillation Anders Albåge, MD, PhD, Ulrik Sartipy, MD, PhD, Göran Kennebäck,

Has the 6-Min Walk Distance Run Its Course?

Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH Heart Rhythm

Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

Evgeny Vaschillo, PhD, Bronya Vaschillo, PhD, Paul Lehrer, PhD CHEST

Counterpoint: Adherence to Early Goal-Directed Therapy

Antithrombotic Therapy for Atrial Fibrillation

Airway Stenting for Patients With Benign Airway Disease and the Food and Drug Administration Advisory Lund Mark E. , MD, FCCP, Force Seth , MD, FCCP

The Extent of Left Atrial Low-Voltage Areas Included in Pulmonary Vein Isolation Is Associated With Freedom from Recurrent Atrial Arrhythmia Dong Huang,

CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation

Volume 145, Issue 1, Pages (January 2014)

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk? Peter J. Zimetbaum, MD, Amit Thosani, MD, Hsing-Ting Yu, MPH, Yan.

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin Keitaro Senoo, MD, Marco Proietti,

Counterpoint: Should All ICU Patients Receive Continuous Sedation? No

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Atul Verma, MD, John A. Cairns, MD, L.

Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation Kareem Bedeir, MBChB, MS, David R. Holmes, MD,

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

Imaging for the Management of Community-Acquired Pneumonia

Augusto Miyashiro, M.D., Soul J. Grosberg, M.D., Simon Wapnick, M.D.

JAMES A. KAUFMANN, M.D., F.C.C.P. Diseases of the Chest

Bedside Calibration Of Pulmonary Artery Catheters

Invasive Pulmonary Aspergillosis

Pulmonary Manifestations in a Case of Multiple Myeloma

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

Volume 10, Issue 9, Pages (September 2013)

Mc Grath Gregory , MD, Das-Gupta Mike , MD, Clarke Geoffrey , MD CHEST

Unusual severe hemodynamic failure associated with standard dose of intravenous flecainide for pharmacological cardioversion of atrial fibrillation Aref.

Volume 42, Issue 2, Pages (August 1962)

Calcification of the Coronary Artery

Digitalis and Angina Pectoris

Erratum Canadian Journal of Cardiology

POINT: Should Inhaled Antibiotic Therapy Be Used Routinely for the Treatment of Bacterial Lower Respiratory Tract Infections in the ICU Setting? Yes

Recurrent Idiopathic Pericarditis: Failure of Corticosteroid Therapy

Figure 8. Stroke prevention strategy in patients with AF

Figure 1. Decision-making process of stroke prevention in patients with AF from Asia. The decision-making process includes stroke risk evaluation, OAC.

NICE 2014 Check pulse in patients presenting with:

Presentation transcript:

Optimizing Atrial Fibrillation Management Allan J. Walkey, MD, D. Kyle Hogarth, MD, FCCP, Gregory Y.H. Lip, MD CHEST Volume 148, Issue 4, Pages 859-864 (October 2015) DOI: 10.1378/chest.15-0358 Copyright © 2015 The American College of Chest Physicians Terms and Conditions

Figure 1 Approach to the short-term and long-term management of new-onset AF during critical illness. The initial approach involves clinical assessment for hemodynamic and respiratory stability related to AF, with evaluation for reversible triggers and initiation of heart rate or rhythm control treatments to meet hemodynamic goals. After clinical improvement, patients should be systematically reevaluated for stroke risk (eg, CHA2DS2-VASc [congestive heart failure, hypertension, age ≥ 75 y, diabetes, previous stroke/transient ischemic attack, vascular disease, age 65-74 y, sex category] score) and evidence of AF recurrence to guide initiation of thromboembolism prophylaxis, rate control, or rhythm control. AF = atrial fibrillation; DCCV = direct current cardioversion. CHEST 2015 148, 859-864DOI: (10.1378/chest.15-0358) Copyright © 2015 The American College of Chest Physicians Terms and Conditions